Technical Analysis for ACIU - AC Immune SA
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 3.54 | -0.84% | -0.03 |
ACIU closed down 0.84 percent on Friday, May 24, 2024, on 49 percent of normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Shooting Star Candlestick | Bearish | 0.00% | |
| Lizard Bearish | Bearish Day Trade Setup | 0.00% | |
| Doji - Bearish? | Reversal | 0.00% | |
| Outside Day | Range Expansion | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Doji - Bearish? | Reversal | -0.84% | |
| Stochastic Reached Overbought | Strength | -0.84% | |
| Wide Bands | Range Expansion | -0.84% | |
| Gapped Up | Strength | -0.84% |
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | 3 days ago |
| Up 5% | 3 days ago |
| Up 3% | 3 days ago |
| Down 1% | 3 days ago |
| Up 2% | 3 days ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 06/21/2024
AC Immune Ltd is a Switzerland-based company engaged in the medical biotechnology sector. It develops treatments for Alzheimer’s and other neurodegenerative diseases, such as Down syndrome, glaucoma and Parkinson's, and focuses on producing therapeutic and diagnostic product candidates, using SupraAntigen and Morphomer technology platforms. The Company's pipeline includes Crenezumab, ACI-24, Anti-Tau antibody, Morphomer Tau, Tau-PET imaging agent, Morphomer Abeta and Morphomer alpha-syn, among others.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biology Organ Systems Imaging Alzheimer's Disease Parkinson's Disease Neurological Disorders Dementia Neurodegenerative Diseases Psychiatric Diagnosis Glaucoma Degenerative Disease Neurodegeneration Imaging Agent Amyloid Beta Company's Pipeline
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biology Organ Systems Imaging Alzheimer's Disease Parkinson's Disease Neurological Disorders Dementia Neurodegenerative Diseases Psychiatric Diagnosis Glaucoma Degenerative Disease Neurodegeneration Imaging Agent Amyloid Beta Company's Pipeline
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 5.14 |
| 52 Week Low | 1.9 |
| Average Volume | 975,926 |
| 200-Day Moving Average | 3.21 |
| 50-Day Moving Average | 2.82 |
| 20-Day Moving Average | 2.90 |
| 10-Day Moving Average | 3.40 |
| Average True Range | 0.28 |
| RSI (14) | 67.53 |
| ADX | 36.85 |
| +DI | 33.63 |
| -DI | 12.37 |
| Chandelier Exit (Long, 3 ATRs) | 3.00 |
| Chandelier Exit (Short, 3 ATRs) | 3.08 |
| Upper Bollinger Bands | 3.93 |
| Lower Bollinger Band | 1.87 |
| Percent B (%b) | 0.81 |
| BandWidth | 70.87 |
| MACD Line | 0.23 |
| MACD Signal Line | 0.14 |
| MACD Histogram | 0.0886 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.08 | ||||
| Resistance 3 (R3) | 4.12 | 3.97 | 3.99 | ||
| Resistance 2 (R2) | 3.97 | 3.84 | 3.96 | 3.96 | |
| Resistance 1 (R1) | 3.76 | 3.75 | 3.69 | 3.72 | 3.93 |
| Pivot Point | 3.61 | 3.61 | 3.58 | 3.60 | 3.61 |
| Support 1 (S1) | 3.40 | 3.48 | 3.33 | 3.36 | 3.15 |
| Support 2 (S2) | 3.25 | 3.39 | 3.24 | 3.12 | |
| Support 3 (S3) | 3.04 | 3.25 | 3.09 | ||
| Support 4 (S4) | 3.00 |
